Background: The EVERREST Prospective Study is a multicentre observational cohort study of pregnancies affected by severe early-onset fetal growth restriction. The study recruits women with singleton pregnancies where the estimated fetal weight is less than the 3rd centile and below 600 g, between 20 + 0 and 26 + 6 weeks of pregnancy, in the absence of a known chromosomal, structural or infective cause.Method: The reported study was retrospective descriptive qualitative interview study of women who had participated in the EVERREST Prospective Study. The aim of this study was to explore the experiences and perceptions of pregnant women taking part in research during a pregnancy affected by severe early-onset fetal growth restriction. Audio-re...
Pregnant women were excluded from clinical trials until the 1990s, but the Food and Drug Administrat...
Objective: to gain insight into the experiences and perspectives of pregnant women diagnosed antenat...
BACKGROUND: Pregnant women were excluded from clinical trials until the 1990s, but the Food and Drug...
Abstract Background: The EVERREST Prospective Study is a multicentre observational cohort study of ...
BACKGROUND: The EVERREST Prospective Study is a multicentre observational cohort study of pregnancie...
Background: The EVERREST Prospective Study is a multicentre observational cohort study of pregnancie...
BACKGROUND: Recruitment of pregnant women to population health research can be challenging, especial...
BACKGROUND: Bioethicists argue that inclusion of pregnant women in clinical research should be more ...
Background: Bioethicists argue that inclusion of pregnant women in clinical research should be more ...
Background: The Midlands and North of England Stillbirth Study (MiNESS) was a case-control study of ...
Abstract Background Bioethicists argue that inclusion of pregnant women in clinical research should ...
Abstract Background The Midlands and North of England Stillbirth Study (MiNESS) was a case-control s...
BACKGROUND: Fetal growth restriction (FGR) is a serious obstetric condition for which there is curre...
Background: Fetal growth restriction (FGR) is a serious obstetric condition for which there is curre...
Background: There is ambiguity with regard to what counts as an acceptable level of risk in clinical...
Pregnant women were excluded from clinical trials until the 1990s, but the Food and Drug Administrat...
Objective: to gain insight into the experiences and perspectives of pregnant women diagnosed antenat...
BACKGROUND: Pregnant women were excluded from clinical trials until the 1990s, but the Food and Drug...
Abstract Background: The EVERREST Prospective Study is a multicentre observational cohort study of ...
BACKGROUND: The EVERREST Prospective Study is a multicentre observational cohort study of pregnancie...
Background: The EVERREST Prospective Study is a multicentre observational cohort study of pregnancie...
BACKGROUND: Recruitment of pregnant women to population health research can be challenging, especial...
BACKGROUND: Bioethicists argue that inclusion of pregnant women in clinical research should be more ...
Background: Bioethicists argue that inclusion of pregnant women in clinical research should be more ...
Background: The Midlands and North of England Stillbirth Study (MiNESS) was a case-control study of ...
Abstract Background Bioethicists argue that inclusion of pregnant women in clinical research should ...
Abstract Background The Midlands and North of England Stillbirth Study (MiNESS) was a case-control s...
BACKGROUND: Fetal growth restriction (FGR) is a serious obstetric condition for which there is curre...
Background: Fetal growth restriction (FGR) is a serious obstetric condition for which there is curre...
Background: There is ambiguity with regard to what counts as an acceptable level of risk in clinical...
Pregnant women were excluded from clinical trials until the 1990s, but the Food and Drug Administrat...
Objective: to gain insight into the experiences and perspectives of pregnant women diagnosed antenat...
BACKGROUND: Pregnant women were excluded from clinical trials until the 1990s, but the Food and Drug...